Estudio comparativo de la eficacia de diversas modalidades terapéuticas en pacientes con blefaritis crónica / Comparative study of the efficacy of different treatment options in patients with chronic blepharitis

OBJETIVO: Comparar la eficacia de 3 modalidades de tratamiento en pacientes con blefaritis crónica. METODOLOGÍA: Se realizó un estudio experimental, aleatorizado y controlado en 45 pacientes (sexo femenino: 67%; edad media: 40,5 años) con diagnóstico de blefaritis crónica para comparar la eficacia de 3 modalidades de tratamiento. Grupo 1: higiene palpebral con champú neutro 3 veces/día; grupo 2: higiene palpebral con champú neutro y gel tópico de metronidazol al 0,75% 2 veces/día; grupo 3: higiene palpebral con champú neutro y pomada antibiótica de neomicina al 3,5% y polimixina al 10% con dexametasona al 0,5% 3 veces/día. Los síntomas y signos fueron valorados asignándoles puntuaciones entre 0: sin síntomas ni signos; 1: síntomas o signos leves; 2: síntomas o signos moderados y 3: síntomas o signos severos. RESULTADOS: En los 3 grupos de tratamiento se observó mejora significativa de los signos y síntomas. Mientras que los grupos 1 y 2 presentaron una mayor mejoría en todas las variables estudiadas (p < 0,05), el grupo 3 no presentó mejoría clínica para comezón (p = 0,16), ojo seco (p = 0,29), caída de pestañas (p = 0,16) ni eritema en el borde palpebral (p = 0,29). CONCLUSIÓN: La higiene palpebral con champú neutro y el uso combinado de champú neutro con gel de metronidazol reportaron mejores resultados que la higiene palpebral con champú neutro y pomada antibiótica de neomicina y polimixina con dexametasona

OBJECTIVE: To compare the efficacy of 3 treatment options in patients with chronic blepharitis. METHODOLOGY: An experimental, randomized, controlled study was conducted on 45 patients (female 67%; Mean age: 40.5 years) diagnosed with chronic blepharitis, in order to compare the effectiveness of three treatment options. Group 1: eyelid hygiene with neutral shampoo three times/day; group 2: neutral shampoo eyelid hygiene plus topical metronidazole gel 0.75% twice/day; group 3: neutral eyelid hygiene with shampoo plus neomycin 3.5% and polymyxin 10% antibiotic ointment with 0.5% dexamethasone 3 times/day. The symptoms and signs were assessed by assigning scores from 0: no symptoms and/or signs; 1: mild symptoms and/or signs, 2: moderate symptoms and/or signs; and 3: severe symptoms and/or signs. RESULTS: A significant improvement was observed in the signs and symptoms in all 3 treatment groups. While groups 1 and 2 had more improvement in all variables studied (P < .05), Group 3 showed no clinical improvement for itching (P = .16), dry eye (P = .29), eyelashes falling (P=.16), and erythema at the eyelid margin (P = .29). CONCLUSIONS: Shampoo eyelid hygiene neutral and neutral shampoo combined with the use of metronidazole gel reported better hygiene results than neutral shampoo lid with antibiotic ointment and neomycin and polymyxin dexamethasone

Comparative study of the efficacy of different treatment options in patients with chronic blepharitis.

OBJECTIVE: To compare the efficacy of 3 treatment options in patients with chronic blepharitis. METHODOLOGY: An experimental, randomized, controlled study was conducted on 45 patients (female 67%; Mean age: 40.5 years) diagnosed with chronic blepharitis, in order to compare the effectiveness of three treatment options. Group 1: eyelid hygiene with neutral shampoo three times/day; group 2: neutral shampoo eyelid hygiene plus topical metronidazole gel 0.75% twice/day; group 3: neutral eyelid hygiene with shampoo plus neomycin 3.5% and polymyxin 10% antibiotic ointment with 0.5% dexamethasone 3 times/day. The symptoms and signs were assessed by assigning scores from 0: no symptoms and/or signs; 1: mild symptoms and/or signs, 2: moderate symptoms and/or signs; and 3: severe symptoms and/or signs. RESULTS: A significant improvement was observed in the signs and symptoms in all 3 treatment groups. While groups 1 and 2 had more improvement in all variables studied (P<.05), Group 3 showed no clinical improvement for itching (P=.16), dry eye (P=.29), eyelashes falling (P=.16), and erythema at the eyelid margin (P=.29). CONCLUSIONS: Shampoo eyelid hygiene neutral and neutral shampoo combined with the use of metronidazole gel reported better hygiene results than neutral shampoo lid with antibiotic ointment and neomycin and polymyxin dexamethasone.

Eficacia de la aplicación tópica de 0, 3% ciprofloxacina en la reducción de la biota conjuntival de pacientes operados de cataratas / Efficacy of topical 0.3% ciprofloxacin application in reducing the conjunctival biota of patients undergoing cataract extraction

Objetivo: Determinar la eficacia de la ciprofloxacina tópica al 0,3% en la reducción de la biota conjuntival en pacientes operados de cataratas. Pacientes y métodos: Estudio experimental, prospectivo, aleatorizado, controlado a simple ciego. Cuarenta y seis ojos de 46 pacientes fueron distribuidos al azar en dos grupos: el grupo de estudio (n = 23) recibió ciprofloxacina al 0,3% un día antes de la cirugía a razón de una gota cada 6 h y, luego, en el día de la cirugía, una gota cada 15 min, empezando una hora antes de la cirugía hasta completar tres dosis; el grupo control (n = 23) no recibió antibiótico; en ambos grupos para el campo quirúrgico se utilizó iodopovidona al 10%. Se tomaron muestras de la conjuntiva en cuatro momentos diferentes, cultivadas en medios sólidos (agar chocolate, agar sangre) y en caldo de enriquecimiento (tioglicolato). Además se obtuvieron muestras de humor acuoso que fueron cultivadas en tioglicolato. La presencia de bacterias fue identificada cuantitativa y cualitativamente y la frecuencia de contaminación fue medida considerando el desarrollo de microorganismos en los medios de cultivo tanto líquido como sólido, y se contabilizaron los números de colonias (UFC) en el sólido. Resultados: Antes de la administración de ciprofloxacina al 0,3% se obtuvieron cultivos positivos en el 82,6 y 78,3% de los pacientes en los grupos de estudio y control, respectivamente. La administración de ciprofloxacina al 0,3% redujo significativamente las UFC en comparación con el grupo control (p < 0,05); inmediatamente después del uso de la iodopovidona el porcentaje de pacientes con cultivo positivo disminuyó a 21,7% en el grupo de estudio y a 8,7% en el grupo control; al final de la cirugía este porcentaje fue de 26 y 30,4%, respectivamente. El germen más frecuente fue el estafilococo coagulasa-negativo (66,7%) (AU)

Conclusión: La administración de ciprofloxacina al 0,3% reduce la carga bacteriana conjuntival en el período preoperatorio, pero no la erradica de forma significativa. La administración de iodopovidona erradica la biota conjuntival en el 50-70% de los pacientes operados de cataratas (AU)

Objective: To determine the efficacy of topical 0.3% ciprofloxacin in reducing conjunctival biota in patients undergoing cataract surgery. Patients and methods: Experimental, prospective, randomized, controlled and single-blind study. Forty-six eyes of 46 patients were randomized into 2 groups, the study group (n = 23) received topical 0.3% ciprofloxacin one day before surgery for six times, and on the day of the surgery one drop every 15 minutes starting one hour before surgery until 3 doses were completed. The control group (n = 23) did not receive any antibiotics. For both groups for the surgical field 10% povidone-iodine was applied. Samples from the conjunctiva were taken at four different times and then cultured on solid media (chocolate agar, blood agar) and enrichment broth (thioglycolate). The aqueous humor samples were also cultured in thioglycolate. The presence of bacteria was identified quantitatively and qualitatively, and the frequency of contamination was measured by considering the presence of bacteria in liquid and solid culture media. The number of colony forming units (CFU) was counted in the solid culture medium. Results: Positive cultures were obtained in 82.6% and 78.2% of the patients in the study and control groups, respectively, before the administration of 0.3% ciprofloxacin. The administration of 0.3% ciprofloxacin significantly reduced the CFU compared to the control group (P < 0.05). Immediately after the use of povidone-iodine, the proportion of patients with a positive culture decreased to 21.7% in the study group, and 8.7% in the control group. At the end of the surgery, this percentage was 26% and 30.4%, respectively. The most common isolated pathogen was negative-coagulase Staphylococcus (66.7%) (AU)

Conclusion: The administration of 0.3% ciprofloxacin reduces conjunctival bacterial load in the preoperative period. However, it was unable to eradicate the bacteria completely. The administration of povidone-iodine reduced conjunctival biota in 50%-70% of patients undergoing cataract surgery (AU)

[Efficacy of topical 0.3% ciprofloxacin application in reducing the conjunctival biota of patients undergoing cataract extraction]. / Eficacia de la aplicación tópica de 0,3% ciprofloxacina en la reducción de la biota conjuntival de pacientes operados de cataratas.

OBJECTIVE: To determine the efficacy of topical 0.3% ciprofloxacin in reducing conjunctival biota in patients undergoing cataract surgery. PATIENTS AND METHODS: Experimental, prospective, randomized, controlled and single-blind study. Forty-six eyes of 46 patients were randomized into 2 groups, the study group (n=23) received topical 0.3% ciprofloxacin one day before surgery for six times, and on the day of the surgery one drop every 15minutes starting one hour before surgery until 3 doses were completed. The control group (n=23) did not receive any antibiotics. For both groups for the surgical field 10% povidone-iodine was applied. Samples from the conjunctiva were taken at four different times and then cultured on solid media (chocolate agar, blood agar) and enrichment broth (thioglycolate). The aqueous humor samples were also cultured in thioglycolate. The presence of bacteria was identified quantitatively and qualitatively, and the frequency of contamination was measured by considering the presence of bacteria in liquid and solid culture media. The number of colony forming units (CFU) was counted in the solid culture medium. RESULTS: Positive cultures were obtained in 82.6% and 78.2% of the patients in the study and control groups, respectively, before the administration of 0.3% ciprofloxacin. The administration of 0.3% ciprofloxacin significantly reduced the CFU compared to the control group (P<.05). Immediately after the use of povidone-iodine, the proportion of patients with a positive culture decreased to 21.7% in the study group, and 8.7% in the control group. At the end of the surgery, this percentage was 26% and 30.4%, respectively. The most common isolated pathogen was negative-coagulase Staphylococcus (66.7%). CONCLUSION: The administration of 0.3% ciprofloxacin reduces conjunctival bacterial load in the preoperative period. However, it was unable to eradicate the bacteria completely. The administration of povidone-iodine reduced conjunctival biota in 50%-70% of patients undergoing cataract surgery.

Simulation of a suite of generic long-pulse neutron instruments to optimize the time structure of the European Spallation Source.

We here describe the result of simulations of 15 generic neutron instruments for the long-pulsed European Spallation Source. All instruments have been simulated for 20 different settings of the source time structure, corresponding to pulse lengths between 1 ms and 2 ms; and repetition frequencies between 10 Hz and 25 Hz. The relative change in performance with time structure is given for each instrument, and an unweighted average is calculated. The performance of the instrument suite is proportional to (a) the peak flux and (b) the duty cycle to a power of approximately 0.3. This information is an important input to determining the best accelerator parameters. In addition, we find that in our simple guide systems, most neutrons reaching the sample originate from the central 3-5 cm of the moderator. This result can be used as an input in later optimization of the moderator design. We discuss the relevance and validity of defining a single figure-of-merit for a full facility and compare with evaluations of the individual instrument classes.

Comparative analysis of the susceptibility to triclosan and three other biocides of avian Salmonella enterica isolates collected 1979 through 1994 and 2004 through 2010.

Few studies have been conducted on changes in the susceptibility of bacteria due to long-term use of biocides. A total of 375 avian Salmonella isolates collected in Germany from healthy or diseased animals during two time periods, 1979 through 1994 and 2004 through 2010, were included in the present study. The isolates were tested for their MICs of triclosan, acriflavine, benzalkonium chloride, and chlorhexidine by broth macrodilution. MIC50, MIC90, and the distribution of MICs were compared. The MIC ranges were 0.0625 to 0.5 µg/ml for triclosan, 16 to 256 µg/ml for acriflavine, 8 to 128 µg/ml for benzalkonium chloride, and 0.5 to 32 µg/ml for chlorhexidine. MIC50s and MIC90s were equal or differed by not more than one dilution step. For isolates from healthy poultry collected during the two time periods, statistical analysis revealed a significant increase only in MICs for chlorhexidine. Salmonellae from diseased birds were more susceptible to triclosan and benzalkonium chloride but less susceptible to acriflavine and chlorhexidine. Overall, only 25 strains had the highest detected MIC of 0.5 µg/ml triclosan, but an association with multidrug resistance could not be confirmed.

Feeding untreated and pasteurized waste milk and bulk milk to calves: effects on calf performance, health status and antibiotic resistance of faecal bacteria.

Non-saleable milk (waste milk, WM) is contaminated with an undefined spectrum of potentially harmful pathogens and antimicrobial residues. The objective of this study was to determine the impact of feeding bulk milk (BM) or WM - both pasteurized or not - on calf performance, health and the antibiotic resistance of specific faecal bacteria. A total of 114 calves from a large-scale dairy were housed outdoors in individual hutches and were randomly assigned to one of four feeding groups. The calves were fed either WM, pasteurized WM (pWM), BM or pasteurized BM (pBM) from day 3 to 56 of life. Milk samples taken from the pasteurizer and calves' nipple buckets were investigated at regular intervals for total plate count and counts of thermoduric bacteria, coliforms and mastitis pathogens. Faecal samples were taken on days 2, 14, 28 and 56 of life from randomly selected calves of the WM, pWM and BM groups (each N = 8-9) and processed to obtain from each sample preferably two isolates of Escherichia (E.) coli and Enterococcus spp. respectively. Isolates were tested for their antimicrobial susceptibility to 25 antimicrobial agents by broth microdilution. Daily weight gain, milk and calf starter intake and health parameters did not differ significantly between the calves of the four feeding groups. The proportion of resistant E. coli isolates was significantly higher in calves fed WM and in calves fed pWM (most pronounced for cephalosporins) than in calves receiving BM. No differences in resistance were found for Enterococus spp. Thus, the concerns for selecting resistant faecal bacteria by feeding WM seem to be justified. Nonetheless, pasteurized WM of cows not treated with antimicrobials represents an acceptable feed for young calves.

Contaminación microbiana de colirios utilizados por pacientes en la consulta externa de oftalmología / Microbial contamination of eye drops used by patients in an outpatient clinic of ophthalmology

Los colirios contaminados representan una causa potencial de infección ocular prevenible. Como toda medicación terapéutica tópica, los colirios deben estar libres de agentes contaminantes. La frecuencia de contaminación varía entre 0,07% y 35,6% en los estudios publicados; no existiendo estudios publicados sobre este tema en nuestro país. Este estudio tiene como objetivo determinar la frecuencia de contaminación de las gotas oftálmicas utilizadas por pacientes que consultan en la Fundación Visión en Asunción, Paraguay. A todos los pacientes que acudieron a la consulta externa en el Servicio de Oftalmología de la Fundación Visión, de agosto de 2007 a julio de 2008 se les solicitó que entregaran sus envases de gotas oftálmicas que estuvieron utilizando por dos o más semanas, además se registraron sus datos demográficos y relacionados al uso del colirio. Los envases fueron enviados al Instituto de Investigaciones en Ciencias de la Salud (IICS), de manera que la medicación restante en el interior de los mismos fuera cultivada en los medios microbiológicos convencionales. De los 73 envases recolectados, 8 (11%) presentaron cultivos positivos, siendo los gérmenes aislados Estafilococo coagulasa negativo, Propionibacterium acnes, Serratia marcescens, Corynebacterium sp y Alcaligenes faecalis, además del hongo oportunista Aspergillus fumigatus. La contaminación de los colirios utilizados por estos pacientes es relevante. Estos resultados coinciden con reportes de otros países y señala la importancia de dar orientaciones a los pacientes en cuanto al modo de utilización, almacenamiento y tiempo de recambio de los colirios por parte de los oftalmólogos.

[Bacterial contamination of needles after intravitreal injection in Paraguay]. / Bakterielle Kontamination von Injektionskanülen nach intravitrealer operativer Medikamenteneingabe in Paraguay.

PURPOSE: The study was designed to prospectively evaluate the bacterial contamination of needles used for intravitreal injection during surgery. MATERIAL AND METHODS: Between December 2007 and December 2010, 549 eyes of 413 patients were treated with intravitreal injections of 1.25 mg bevacizumab. Of the patients 322 received a single injection and 91 multiple injections. Preoperatively the periorbital skin of all patients was treated with 10% povidone iodine (PVI) and the conjunctival sac was irrigated with 1% PVI. No pre-injection antibiotics were administered. Immediately after the injection the needles were rinsed 3 times in thioglycolate broth which was then cultured at 37°C for 5 days. As a negative control 73 sterile unused needles were treated in the same way. RESULTS: Out of the 549 needle points tested 8 (1,45%) were found to be contaminated after intravitreal injections. The isolated bacteria were coagulase negative Staphylococcus (n = 7), Propionibacterium acnes (n = 1) and Klebsiella pneumoniae (n = 1) (co-contamination in one case). CONCLUSION: Contamination of needles is minimal after prophylactic povidone iodine irrigation before intravitreal injections. Therefore, this prophylaxis technique is recommended before intravitreal injections in order to prevent postoperative infections.

[Persistent contact lens-associated keratitis]. / Persistierende kontaktlinsenassoziierte Keratitis.

A 43-year-old woman presented with a 2-month history of contact lens-associated keratitis and corneal ulceration on the left eye. Without having isolated the pathogenic agent, a calculated anti-infective and anti-inflammatory therapy had already been administered with no signs of improvement. Filamentous fungi (Acremonium sp) were found in the scraping material and the contact lens solution. A keratoplasty à chaud was necessary despite immediate initiation of pathogen-specific therapy. Early identification of the pathogen via corneal debridement and culturing are standard procedures in order to initiate a specific therapy and prevent ulceration which can threaten the visual outcome.

[Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application]. / Moxifloxacin intrakameral: Eine sichere Option zur Endophthalmitisprophylaxe? In-vitro-Sicherheitsprofil zur intraokularen Anwendung.

BACKGROUND: Moxifloxacin (Vigamox), a 4th-generation fluoroquinolone, covers most isolates causing endophthalmitis. It is safe and effective for systemic and topical use; however, only very limited data are available on prophylactic intracameral administration to prevent endophthalmitis. This study investigated the safety of Vigamox for intracameral application in a cell-culture model. METHODS: The endothelial toxicity of moxifloxacin (Vigamox) was evaluated in cultured human corneas. Primary human retinal pigment epithelium cells (RPEs), trabecular meshwork cells (TMCs), lens epithelium cells (LECs), and corneal endothelial cells (CECs) were treated with concentrations of Vigamox. Toxic effects were evaluated after 24 h (MTT assay and live-dead assay). By treating TMC, CEC, and RPE cells either with oxidative stress or tumor necrosis factor-alpha (TNF-a), lipopolysaccharide (LPS), and interleukin-6 (IL-6), the effects of moxifloxacin on cellular viability under conditions of inflammation were investigated. RESULTS: No corneal endothelial toxicity could be detected after 30 days of treatment with moxifloxacin 500 microg/ml. Primary RPEs, TMCs, LECs, and CECs showed adverse effects on proliferation and viability only at concentrations higher than 150 microg/ml moxifloxacin. After preincubation with TNF-a, LPS, and IL-6 for 24 h and subsequent treatment with moxifloxacin at concentrations of 10-150 microg/ml for 24 h, no significant decrease in proliferation or viability was observed. H2O2 exposure did not increase cellular toxicity CONCLUSION: Vigamox did not show significant toxicity on primary RPEs, TMCs, LECs, CECs, or human corneal endothelium at concentrations up to 150 microg/ml. The MIC90 of moxifloxacin for pathogens commonly encountered in endophthalmitis is known to be in the range of 0.25-2.5 microg/ml. Therefore, intracameral use of Vigamox at concentrations up to 150 microg/ml may be safe and effective for preventing endophthalmitis after intraocular surgery.

Two pathogens of Greenshell mussel larvae, Perna canaliculus: Vibrio splendidus and a V. coralliilyticus/neptunius-like isolate.

Bacterial pathogens of Greenshell mussel (GSM) larvae can cause batch losses during hatchery production. Twenty-two isolates were screened using a larval bioassay. Two strains were identified as potential pathogens. Phenotypic identification of these strains revealed two non-reactive Gram-negative, oxidase positive rods. Sequencing of the 16S rRNA gene identified Vibrio splendidus and a V. coralliilyticus/neptunius-like isolate as pathogens of GSM larvae, with an ability to cause 83% and 75% larval mortality in vitro, respectively, at a concentration of 10(2) CFU mL(-1). Histopathology indicated that the route of infection was via the digestive system. Using healthy larvae as target hosts, Koch's postulates were confirmed for the two isolates. This is the first report on pathogens of GSM larvae.

In vitro antibiotic susceptibility of preoperative normal conjunctival bacteria.

PURPOSE: To determine the antibiotic susceptibility of preoperative conjunctival bacterial flora. METHODS: Antibiotic susceptibility of conjunctival bacterial strains isolated from 142 patients undergoing intraocular surgery was determined using the Kirby-Bauer disc diffusion technique. chi(2) statistical analysis was performed. RESULTS: Among the 116 bacteria isolated, 95 (82%) were coagulase-negative staphylococci (CNS). Most (>75%) of them were susceptible to vancomycin, minocycline, aminoglycosides, gatifloxacin, levofloxacin, and moxifloxacin. Approximately one-half of CNS was resistant to erythromycin and azithromycin. Over 90% of streptococci were susceptible to levofloxacin, moxifloxacin, and gatifloxacin. RESULTS: Fluoroquinolones, specifically gatifloxacin, levofloxacin, and moxifloxacin continue to provide broad-spectrum coverage against common conjunctival bacterial flora.

Frecuencia y sensibilidad antimicrobiana de agentes etiológicos de dacriocistitis / Frequency and antimicrobial sensibility of etiological agents of dacriocystitis

La dacriocistitis representa la infección más frecuente del sistema lagrimal. El estudio microbiológico de las dacriocistitis es importante para la adecuada selección de los antibióticos. El objetivo del estudio es determinar la frecuencia y sensibilidad antimicrobiana de los agentes causantes de dacriocistitis en pacientes que acudieron a la Cátedra de Oftalmología del Hospital de Clínicas de mayo de 1998 a abril de 2007. Los pacientes no recibieron antibióticos por lo menos por una semana antes de la toma de muestra, que fueron tomadas por aspiración del contenido del saco lagrimal por el canalículo inferior o punción directa del saco lagrimal, y cultivadas en aerobiosis y anaerobiosis siguiendo métodos convencionales. De 41 pacientes (23 adultos y 18 niños), 30 (73,1%) presentaron cultivos positivos; 16 (53.4%) monomicrobianos y 14 (46,6%) polimicrobianos. Se aislaron 51 microorganismos, 37 en adultos y 14 en niños. El 54% de los microorganismos aislados en muestras de adultos correspondió a bacilos gramnegativos (enterobacterias, Haemophilus sp, anaerobios, y bacilos gramnegativos no fermentadores); 41% a cocos grampositivos (Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus viridans, y estafilococo coagulasa negativo); el 72% de los micro-organismos aislados en niños correspondió a cocos grampositivos (Staphylococcus aureus y Streptococcus pneumoniae), y en una muestra se aisló Candida sp. La sensibilidad del Streptococcus pneumoniae a la penicilina y la del Staphylococcus aureus a la meticilina fue de 100%. Los microorganismos aislados presentaron buena sensibilidad a los antimicrobianos, pero por la gran variedad de microorganismos y la naturaleza polimicrobiana de los cultivos se debería ampliar el esquema inicial de tratamiento y de la profilaxis de la dacriocistorrinostomía y otros procedimientos intraoculares. Una opción es el uso de aminopenicilinas con un inhibidor de betalactamasa; asociado con colirio de tobramicina en niños y ciprofloxacina en adultos.

Dacryocystitis is the most frequent infection of the lacrimal sac. The microbiological evaluation of dacryocystitis is important to make an adequate choice of antibiotics. The objective of this study is to determine the frequency and antibiotic susceptibility of the etiological agents of dacryocystitis in patients attending the Ophthalmology Department of the Teaching Hospital of the National University of Asunción, Paraguay from May 1998 to April 2007. All patients were antibiotic-free for at least one week prior to sampling. Samples were taken by aspiration of the lacrimal sac obtained via canalicular reflux or incision of the lacrimal sac and cultured aerobically and anaerobically following standard methods. Out of 41 patients (23 adults and 18 children), 30 (73.1%) showed positive cultures, 16 (53.4%) of them were pure and 14 (46.6%) mixed cultures, yielding 51 microorganisms. Of the 37 microorganisms 54% were isolated in adults and corresponded to gram negative rods (enterobacterias, Haemophilus sp, anaerobic and non fermenting gram negative rods) while 41% to gram positive cocci: (Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus viridans, coagulase negative Staphylococcus). In children, 72% of the micro-organisms isolated were gram positive cocci (Staphylococcus aureus and Streptococcus pneumoniae) and Candida sp was found in one sample. The susceptibility patterns of the Streptococcus pneumoniae to penicillin and Staphylococcus aureus to methicillin were 100%. All isolates showed high susceptibilities to the tested antibiotics. However, due to the great variety of species and the polymicrobial nature of the cultures, the initial scheme and prophylaxis of the dacryocystorhinostomy and other intraocular procedures should be expanded. One option is the use of aminopenicillins with a betalactamase inhibitor associated with tobramycin in children and ciprofloxacin in adults.

[Chronic endogenous endophthalmitis]. / Chronische endogene Endophthalmitis.

An endogenous endophthalmitis is a severe, potentially blinding intraocular infection due to haematogenous spread of germs. In Europe, gram-positive bacteria and Candida albicans are common causative organisms. Compared to post-operative cases of endophthalmitis, endogenous endophthalmitis is relatively rare, accounting for 2-8% of all endophthalmitis cases. Most patients suffer from an underlying disease causing some kind of immunodeficiency. Other predisposing factors are long-term therapy in intensive-care units (ICU), intravenous catheters, iatrogenic immunosuppression or intravenous drug abuse. Final visual acuity strongly depends on the time needed for the correct diagnosis, the infectious agent and the selection of adequate treatment. Identification of the infectious agent by vitreous biopsy and blood cultures enables the ophthalmologist to choose a specific antibiotic treatment. Therapy consists of topical, intravitreal and systemic antibiotics or antimycotics often in combination with steroids and pars plana vitrectomy. As many of the patients with endogenous endophthalmitis are initially misdiagnosed (e. g. uveitis), it is important to consider this disease in the presence of suspicious symptoms.

Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate.

The induction of tolerance towards allogeneic solid organ grafts is one of the major goals in transplantation medicine. Mesenchymal stem cells (MSC) inhibit the immune response in vitro, and thus are promising candidate cells to promote acceptance of transplanted organs in vivo. Such novel approaches of tolerance induction are needed since, to date, graft acceptance can only be maintained through life-long treatment with unspecific immunosuppressants that are associated with toxic injury, opportunistic infections and malignancies. We demonstrate that donor-derived MSC induce long-term allograft acceptance in a rat heart transplantation model, when concurrently applied with a short course of low-dose mycophenolate. This tolerogenic effect of MSC is at least partially mediated by the expression of indoleamine 2,3-dioxygenase (IDO), demonstrated by the fact that blocking of IDO with 1-methyl tryptophan (1-MT) abrogates graft acceptance. Moreover we hypothesize that MSC interact with dendritic cells (DC) in vivo, because allogeneic MSC are rejected in the long-term but DC acquire a tolerogenic phenotype after applying MSC. In summary, we demonstrate that MSC constitute a promising tool for induction of non-responsiveness in solid organ transplantation that warrants further investigation in clinical trials.

Queratitis infecciosas: características clínicas y microbiológicas: período 2003-2006 / Infectious keratitis: clinical and microbiological characteristics: 2003-2006 period

Las queratitis infecciosas poseen una elevada morbilidad, poniendo en riesgo la visión sino son tratadas rápida y apropiadamente. El objetivo del presente estudio es evaluar lascaracterísticas clínicas y microbiológicas, el tratamiento implementado y la evoluciónclínic120.A los dos meses del post-tratamiento en pacientes con queratitis infecciosas queconsultaron en el Departamento de Oftalmología del Hospital de Clínicas entre julio de2003 a diciembre de 2006. De 167 pacientes, 74,3% eran varones; la edad media ± DEfue de 40 ± 19 años. Los cultivos fueron positivos en el 71,9% de los casos; aislándosebacterias como único agente etiológico en el 43,7%; exclusivamente hongos 17,4%;hongos y bacterias 10,8%. Entre las bacterias aisladas se encontraron, estafilocococoagulasa-negativa (29%), Pseudomonas aeruginosa (16%), Streptococcus pneumoniae(10,5%) y Staphylococcus aureus (8,1%) y entre los hongos Fusarium sp (57,4%). De154 pacientes, que tenían datos sobre el tratamiento empleado, el 77,8% recibió colirioreforzado de cefazolina 50 mg/ml y gentamicina 16mg/ml; 33,5% fluconazol y 12%ciprofloxacina. Se tuvo información sobre la evolución a los dos meses en 133 pacientes,de los cuales el 82% presentó leucoma, 13,5% recubrimiento conjuntival y 4,5%evisceración. Una mala evolución estuvo asociada al origen micótico y al tamaño grandede la úlcera. La frecuencia de las queratitis infecciosas de origen micótico es alta en estaserie, y relacionada con una peor evolución. El fluconazol es el único antimicóticodisponible en nuestro medio, pero su efecto es principalmente sobre hongos nofilamentosos, por lo tanto se deberían incorporar nuevos esquemas de tratamientoantimicótico, como la natamicina, que podría evitar la pérdida de la visión de numerosos pacientes

Prospective randomized comparison of 1-day versus 3-day application of topical levofloxacin in eliminating conjunctival flora.

PURPOSE: To compare efficacy of a 1-day versus 3-day application of topical levofloxacin in reducing ocular surface bacteria. METHODS: In this prospective randomized controlled trial, 100 volunteer patients (50 per group) were assigned to receive topical 0.5% levofloxacin four times daily for 1 day or 3 days. Conjunctival cultures were obtained prior to (T0) and after the application of antibiotics (T1). Additionally, all patients received topical levofloxacin at 5-minute intervals for three applications (T2), followed by two drops of topical 5% povidone-iodine (T3). Conjunctival cultures were obtained at timepoints T2 and T3. RESULTS: A 1-day application of topical levofloxacin significantly reduced (p = 0.0004) the number of eyes with positive conjunctival cultures from 41 eyes (82%) to 23 eyes (46%). Similarly, a 3-day application significantly reduced (p = 0.0001) the positive culture rate from 37 eyes (74%) to 17 eyes (34%). Two drops of povidone-iodine further reduced the positive culture rate for both groups to 20% (10 eyes for each group). There was no significant difference in positive culture rate between the 1-day and 3-day groups at T0 (p = 0.4689), T1 (p = 0.3074), T2 (p = 0.6706), or T3 (p = 1.000). CONCLUSIONS: The application of topical 0.5% levofloxacin for 1 or 3 days significantly reduced the number of eyes with positive conjunctival cultures. The addition of 5% povidone-iodine further eliminated bacteria from the conjunctiva. The application of levofloxacin for 1 day appears to be as effective as a 3-day application.

Actividad in vitro de fluoroquinolonas en bacilos gramnegativos aislados deurocultivos de pacientes ambulatorios / In vitro activity of fluoroquinolones in gramnegative rods isolated from ambulatory patients urocultures

Las fluoroquinolonas constituyen un grupo de antibióticos, ampliamente utilizado en infeccionesdel tracto urinario (ITU), por su excelente actividad frente a las enterobacterias y por su vía deeliminación. El objetivo de este estudio es determinar la resistencia a las fluoroquinolonas:ciprofloxacina, levofloxacina y gatifloxacina en bacilos gramnegativos aislados de ITU. Se incluyeronen el estudio todos los bacilos gramnegativos, aislados de pacientes adultos con ITU, queconcurrieron en forma consecutiva al laboratorio San Roque, desde junio de 2005 a marzo de 2006.Para determinar la resistencia, se utilizó el método de difusión en agar siguiendo normasestandarizadas del NCCLS. De las 380 cepas aisladas el 81,7% correspondió a Escherichia coli,11,6% Klebsiella pneumoniae, 3,4% Proteus mirabilis, 1% Enterobacter aerógenes, 0,8%Enterobacter cloacae, 0,5% Citrobacter koseri, 0,5% Citrobacter freundii y 0,5% Klebsiella oxytoca.El 17,6% de todos los aislamientos, fue resistente a todas las fluoroquinolonas ensayadas (58cepas de E. coli, 7 cepas de K. pneumoniae y 2 de E. cloacae). La resistencia de E. coli a las tresfluoroquinolonas fue del 18,7%, y de K. pneumoniae 15,9%. Una cepa de E. coli, sensible agatifloxacina, presentó sensibilidad intermedia a ciprofloxacina y levofloxacina. Las tresfluoroquinolonas testadas presentaron igual actividad frente a bacilos gramnegativos, aislados deITU. Esta resistencia es relativamente alta, debido a que la resistencia a un antibiótico a serutilizado en forma empírica, no debe superar el 20%

[The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva]. / Wirksamkeit neuer Fluorchinolone gegenüber der bakteriellen Normalflora der Bindehaut.

BACKGROUND: Our aim was to determine the antibiotic susceptibility of the preoperative conjunctival bacterial flora against 25 commonly used antibiotics, especially the new fluoroquinolones levofloxacin, gatifloxacin, and moxifloxacin. PATIENTS AND METHODS: The Kirby-Bauer disk-diffusion technique was used to test for the in vitro antibiotic susceptibility of conjunctival bacterial strains isolated from 160 patients (median=74 years, mean=71 years) undergoing cataract surgery at the Department of Ophthalmology, Stanford University, CA, USA. RESULTS: Among the 256 bacteria isolated, 201 (79%) were coagulase-negative staphylococci (CNS), 26 Staphylococcus aureus, 15 Streptococcus group D and 14 gram-negative rods. A total of 100 of these 256 strains (39%) were classified as multiresitant (resistant to>or=five antibiotics). The resistance rate (RR) of commonly used antibiotics for all CNS was: gatifloxacin=moxifloxacin